Efficacy of Seprafilm for prevention of delayed gastric emptying after left-sided hepatectomy: clinical study

Efficacy of Seprafilm for prevention of delayed gastric emptying after left-sided hepatectomy: clinical study - Prevention of DGE by Seprafilm after left-sided hepatectomy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000032684

Enrollment

100

Registered

2018-07-01

Start date

2018-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver tumor to be indicated for left-sidied hepatectomy

Interventions

Satndard therapy group (no seprafilm) Trial therapy group (Seprafilm)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patients who have liver tumor to be indicated left-sided hepatectomy 2)Preoperative ECOG Performance Status is 0-1 3)Age over 20 years old at the day of surgery 4)Those whose written consent has been obtained

Exclusion criteria

Exclusion criteria: 1)Patients who schedule to resect other organs (except gallbladder) 2)Patients who schedule to rebuild biliary duct 3)Patients who underwent gastrectomy 4)Patients with a history of severe hypersensitivity 5)Patients who have severe comorbidity 6)Patients who abuse drug Patients who is mentally unstable Patients who is difficult to communicate with a doctor 7)Patients during pregnancy or at risk of becoming pregnant Others:Patients considered inappropriate by the study investigator

Design outcomes

Primary

Measure	Time frame
Frequency of delayed gastric emptying	—

Countries

Japan

Contacts

Public ContactHidetoshi Eguchi

Osaka University Department of Gastroenterological Surgery

heguchi@gesurg.med.osaka-u.ac.jp06-6879-3251

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026